Recall archive / FDA drug enforcement
0.9% Sodium Chloride Injection USP 500 mL, VIAFLEX Plastic Containers, with 24 units per case. Baxter Healthcare Corp... — FDA record D-0849-2026
Reported ongoing
Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.
Source date Aug 17, 2026. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
What the record says
- Product
- 0.9% Sodium Chloride Injection USP 500 mL, VIAFLEX Plastic Containers, with 24 units per case. Baxter Healthcare Corporation, Deerfield, IL, 60015, USA, Made in USA, NDC 0338-0049-03
- Reason
- Presence of particulate matter: Particulates identified as fiberglass
- Classification
- Class I
- Recalling firm
- Baxter Healthcare Corporation
- Quantity
- 145,464 500mL bags
- Agency-reported status
- Ongoing
- Source record identifier
- D-0849-2026
What the recall classes mean. Classification is an agency assessment, not individual medical advice.
Lot and product identifiers
| Label field | Details supplied by the agency |
|---|---|
| Lot, code or applicability | Lot: Y495523, Y495523A, Exp 31-Oct-2027 |
Match all identifying details in the current notice. A brand name alone is not enough.
Distribution
Natonwide in the USA
No US distribution state could be established from this record. Check the official notice.
Dates in the source
- Report date
- Sep 9, 2026
- Recall initiation date
- Aug 17, 2026
- Center classification date
- Sep 15, 2026
FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.